【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Overview 11
Therapeutics Development 12
Pipeline Products for Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Overview 12
Pipeline Products for Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Comparative Analysis 13
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics under Development by Companies 14
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics under Investigation by Universities/Institutes 17
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Products under Development by Companies 22
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Products under Investigation by Universities/Institutes 25
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Companies Involved in Therapeutics Development 26
AnGes MG, Inc. 26
AstraZeneca PLC 27
Bayer AG 28
Biosidus S.A. 29
Biscayne Pharmaceuticals, Inc. 30
Bristol-Myers Squibb Company 31
Cardiome Pharma Corp 32
CardioVascular BioTherapeutics, Inc. 33
Eagle Pharmaceuticals, Inc. 34
Gilead Sciences, Inc. 35
Hemostemix Ltd 36
Human Stem Cells Institute 37
Isis Pharmaceuticals, Inc. 38
Juventas Therapeutics, Inc. 39
Lacer, S.A. 40
Lee’s Pharmaceutical Holdings Limited 41
Lonestar Heart, Inc. 42
MedImmune, LLC 43
Merck & Co., Inc. 44
Miltenyi Biotec GmbH 45
Multi Gene Vascular Systems Ltd 46
Nuo Therapeutics, Inc. 47
Pluristem Therapeutics Inc. 48
Regado Biosciences, Inc. 49
The Medicines Company 50
ViroMed Co., Ltd. 51
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics Assessment 52
Assessment by Monotherapy Products 52
Assessment by Target 53
Assessment by Mechanism of Action 55
Assessment by Route of Administration 57
Assessment by Molecule Type 59
Drug Profiles 61
ACP-01 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
ALD-201 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
anacetrapib – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Aptamers for Cardiovascular Diseases – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
BAY-606583 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
beperminogene perplasmid – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Biglycan Therapy for Cardiovascular Diseases – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
BIS-5409 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
bivalirudin – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
bivalirudin – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
BQ-123 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
C2 ceramide – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
C6 ceramide – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
cangrelor – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
CAP-1002 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Cryocell – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
CVBT-141H – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
Gemacell – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Diseases – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
Gene Therapy to Activate VEGF for Ischemia – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
ISIS-APOARx – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
ISIS-CRPRx – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
JVS-100 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
LA-419 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
MEDI-6012 – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
Monoclonal Antibody to Inhibit CD20 for Cardiovascular Disease – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
MultiGeneGraft – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
MZ-004 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
Oligonucleotides for Ischemic Heart Disease and Duchenne Muscular Dystrophy – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Proteins for Ischemic Heart Disease – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
ranolazine ER – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
rivaroxaban – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
Small Molecule for Coronary Artery Disease – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
Stem Cell Therapy for Cardiovascular Disease – Drug Profile 113
Product Description 113
Mechanism of Action 113
R&D Progress 113
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 115
Product Description 115
Mechanism of Action 115
R&D Progress 115
Synthetic Peptides to Modulate CD36 Receptor for Ischemic Heart Disease and Macular Degeneration – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
tirofiban hydrochloride – Drug Profile 119
Product Description 119
Mechanism of Action 119
R&D Progress 119
VM-202 – Drug Profile 121
Product Description 121
Mechanism of Action 121
R&D Progress 121
XL-652 – Drug Profile 123
Product Description 123
Mechanism of Action 123
R&D Progress 123
ZK-001 – Drug Profile 125
Product Description 125
Mechanism of Action 125
R&D Progress 125
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Recent Pipeline Updates 127
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Dormant Projects 155
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Discontinued Products 158
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Product Development Milestones 159
Featured News & Press Releases 159
Nov 14, 2014: The Medicines Company to Present New Data on Investigational Antiplatelet Agent Cangrelor at 2014 AHA Annual Scientific Sessions in Chicago 159
Oct 27, 2014: The Medicines Company Wins Favorable Judgment in Angiomax (Bivalirudin) Patent Litigation 159
Oct 06, 2014: Capricor Announces Plans to Pursue Clinical Program for the Treatment of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs) 160
Sep 02, 2014: Isis Pharmaceuticals Presents Data On ISIS-APO(A)RX At European Society of Cardiology Congress 2014 160
Jul 07, 2014: The Medicines Company Receives Market Authorization Renewal for Angiox (Bivalirudin) from the European Medicines Agency and the European Commission 161
Apr 28, 2014: The Medicines Company Files Petition Against Aurobindo Over Patent Infringement 162
Mar 30, 2014: Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines Company’s Angiomax Presented at ACC.14 162
Dec 23, 2013: European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Cangrelor 163
Oct 11, 2013: Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT 164
Oct 09, 2013: First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax in Patients Undergoing Peripheral Endovascular Procedures 164
Appendix 166
Methodology 166
Coverage 166
Secondary Research 166
Primary Research 166
Expert Panel Validation 166
Contact Us 167
Disclaimer 167
【レポート販売概要】
■ タイトル：冠動脈疾患(CAD)(虚血性心疾患)の治療薬パイプライン動向（2015年上半期版）■ 英文：Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6034IDB
■ 調査対象地域：グローバル
- 膝関節再建デバイスの世界市場分析・予測（～2020）The report on the global knee reconstruction devices market analyzes and segments the concerned market on the basis of product type and geography. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global knee reconstruction devices market. This market is also studied with an explicit focus on the high-growth applications and fastest-grow …
- 栄養・健康成分としての果物及びベリー：グローバル市場トレンドとインサイトSummary This report analyses the most popular used fruit and berries, how they are sourced and used in industry processed formats as food ingredients. How the fruits has roles traditionally as flavors and colors within the global soft drinks industry and the new potential of bringing nutrition and health benefits as well. A short review of current claims situation and the most prospect fruit based …
- 中国の乗用車市場：セダン・小型車、SUV/クロスオーバー、MPV、高級車About the Passenger Vehicle Market in China China is leading the global automotive industry since 2009, when it overtook the US in terms of total vehicle production. China represents one of the fastest-growing auto industries and is one of the key regions for original equipment manufacturers (OEMs) across the globe. Passenger cars are a key segment of the automotive industry in China. This segment …
- 2,3-ジメチル-4-ニトロピリジンN-オキシドの世界市場2,3-Dimethyl-4-nitropyridine-N-oxide (CAS 37699-43-7) Market Research Report 2014 presents comprehensive data on 2,3-dimethyl-4-nitropyridine-n-oxide markets globally and regionally (Europe, Asia, North America etc.) The report includes 2,3-dimethyl-4-nitropyridine-n-oxide description, covers its application areas and related patterns. It overviews 2,3-dimethyl-4-nitropyridine-n-oxide market, name …
- 合わせガラスの世界市場予測（～2022年）：ポリビニルブチラール、イオノプラストポリマーThe laminated glass market is projected to reach USD 23.04 Billion by 2022, at a CAGR of 6.02% from 2017 to 2022. The growing demand from the building & construction industry is expected to drive the laminated glass market. Based on end-use industry, the building & construction industry is estimated to witness a higher growth than the automotive industry between 2017 and 2022. The growth in buildi …
- 世界のスマートテレビ向け動画配信サービス市場About Video Services on Connected TV Video services on connected TVs are provided by various websites that distribute online content provided by content developers. These services enable users to order content online, without downloading it, to watch it on their TV. Connected TVs allow viewers to access online content from their TVs without using their PCs or laptops, and the devices used for this …
- ベネズエラの水力発電市場2016：発電能力、生産、投資動向、制度、企業Hydropower in Venezuela, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Hydropower in Venezuela, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry …
- 電気生理学的検査用カテーテル（医療機器）のグローバル市場（2012-2018）Global Diagnostic Electrophysiology Catheters sector is projected to reach US$3.5 billion by 2016. The North America accounts for nearly 34% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 13.2% driving a market value of US$857 million by 2015. On a global scale, projections for Conventional EP Diagnostic Catheters …
- ライダーの世界市場：空中LiDAR、地上LiDAR、UAV LiDARLiDAR market was valued USD at 1.39 Billion in 2015 and is estimated to reach USD 3.22 Billion by 2022, at a CAGR of 12.4% between 2016 and 2022. The market growth is attributed to the encouragement of government and institutes for adoption of LIDAR. Automation that leads to increased efficiency and reduced human efforts is also a reason for the impressive growth of the market. It has applications …
- 松材原料化学品の世界市場：トール油脂肪酸、トール油ロジン、ガムテレピン油、ガムロジン、ピッチ、ステロールThe pine-derived chemicals market has grown exponentially in the last few years and this trend is projected to continue. The market was valued at $4.8 billion in 2014 and is projected to grow at a CAGR of 4.7% from 2015 to 2020. IT is primarily driven by factors such as the need to use renewable resources in the manufacturing processes and reducing carbon footprint. The pine-derived chemicals mark …
- エポキシ樹脂の世界市場分析：用途別（塗料・コーティング、風力タービン、複合材料、建設、電気・電子、接着剤）、セグメント予測The global epoxy resin market is expected to reach USD 14.26 billion by 2024, according to a new report by Grand View Research, Inc. The market is anticipated to be driven by end-use industries including automotive, aerospace, transportation, composites, decorative coatings, construction, industrial & marine coatings, electrical & electronics, especially in Asia Pacific. Epoxy resins are the most …
- 世界の家電市場展望（～2015年）（Global Consumer Electronics Market Outlook 2015）The growing convergence of information, communication and entertainment is bringing a new era of consumer electronics across the world. Consumer electronics is one of the largest segments in the manufacturing industry and promises huge potential, particularly in emerging markets. With increasing household income levels, local manufacturing, launch of innovative technological products and rising aw …
- 建設用化学製品の世界市場：コンクリート混和材、建設用接着剤、建設用シーラント、難燃剤The construction chemicals market is estimated to reach USD 33.98 Billion in terms of volume by 2020, signifying a high CAGR of over 7.62% between 2015 and 2020. The construction chemicals market registered a high growth in the past few years which is estimated to continue in the coming years supported by growing construction industry in Asia-pacific and RoW regions. The demand for construction ch …
- 自動車用サスペンションコイルスプリングの世界市場2019-2023About this market Automobiles are becoming intelligent and smarter in terms of functionality and capabilities. This is because modern vehicles are finding greater application of electronics at the systems and components levels during the designing and manufacturing processes. Automotive components and parts made using materials such as steel, aluminum and others are helping improve performance, re …
- 世界の結晶果糖市場2015The 2015 Deep Research Report on Global Crystalline Fructose Industry is a professional and in-depth study on the current state of the Crystalline Fructose industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Crystalline Fructose market analysis is provided for the international markets including devel …
